Comparison between Infinium Pharmachem IPO and Nirman Agri Genetics IPO.
Infinium Pharmachem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Nirman Agri Genetics IPO is a SME Fixed Price proposed to list at NSE SME.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | First Overseas Capital Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Swastika Investmart Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹23.99 Cr whereas the issue size of the Nirman Agri Genetics IPO is up to ₹19.27 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Nirman Agri Genetics IPO is ₹99.00 per share.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹135.00 per share | ₹99.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹13.50 per share | |
| Market Lot Size | 1000 shares | 1200 shares |
| Fresh Issue Size | 17,81,000 shares | 19,46,400 shares |
| Fresh Issue Size (Amount) | up to ₹23.99 Cr | up to ₹19.27 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,81,000 shares | 19,46,400 shares |
| Issue Size Total (Amount) | up to ₹23.99 Cr | up to ₹19.27 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Nirman Agri Genetics IPO opens on Mar 15, 2023. The closing date of Infinium Pharmachem IPO and Nirman Agri Genetics IPO is Apr 05, 2023, and Mar 20, 2023, respectively.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 31, 2023 | Mar 15, 2023 |
| Issue Close | Apr 05, 2023 | Mar 20, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Mar 23, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Mar 24, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Mar 27, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Mar 28, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Nirman Agri Genetics IPO P/E ratio of 14.93.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.05 | 65.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 7.83 | 14.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.93 Cr. | ₹59.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.85 | 96.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 72 | 65.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.91 | 0.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹54.13 | ₹10.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 46.61 | 96.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Infinium Pharmachem IPO Retail Individual Investors (RII) are offered 8,70,000 shares while in Nirman Agri Genetics IPO retail investors are offered 8,70,000 shares. Qualified Institutional Buyers (QIB) are offered in Infinium Pharmachem IPO and in Nirman Agri Genetics IPO.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 94,000 shares | 1,04,400 shares |
| QIB | ||
| NII | 8,70,000 shares | 9,73,200 shares |
| RII | 8,70,000 shares | 9,73,200 shares |
| Employee | 41,000 shares | |
| Others | ||
| Total | 17,81,000 shares | 19,46,400 shares |
Infinium Pharmachem IPO subscribed 1.92x in total, whereas Nirman Agri Genetics IPO subscribed 1.71x.
| Infinium Pharmachem IPO | Nirman Agri Genetics IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.94x | 1.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.00x | 2.20x |
| Employee (times) | 1.29x | |
| Other (times) | ||
| Total (times) | 1.92x | 1.71x |
